KP Tissue Q2 2024 Earnings Call Transcript

Quartr
Provided by Quartr
August 13, 2024

There are 7 speakers on the call.

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to KP Tissue Second Quarter 2024 Results Conference Call. At this time, all participants are in a listen only mode. Following the presentation, we will conduct a question and answer session.

Operator

Instructions will be provided at that time for you to queue up for questions. Before turning the meeting over to management, I would like to remind everyone that this conference call is being recorded on Tuesday, August 13, 2024. I would now like to turn the conference over to Mike Baldacera, Director, Investor Relations. Please go ahead, sir.

Speaker 1

Thank you, operator, and good morning, ladies and gentlemen. My name is Mike Baldessera. I'm the Director of Investor Relations at KP Tissue Inc. The purpose of this conference call is to review the financial results of the Q2 of 2024 of Kruger Products Inc, which I'll refer to as Kruger Products going forward. With me this morning is Dino Bianco, our Chief Executive Officer of KP Tissue and Kruger Products and Michael Keyes, the Chief Financial Officer of KP Tissue and Kruger Products.

Speaker 1

The following discussions and responses to questions contain forward looking statements concerning the company's activities. Forward looking statements involve known and unknown risks and uncertainties, which could cause the company's actual results to differ materially from those in the forward looking statements. Investors are cautioned not to rely on these forward looking statements. The company does not undertake to update these forward looking statements except if required by applicable laws. There's a page at the beginning of the written presentation, which contains the usual legal cautions, including as to forward looking information, which you should be aware of.

Speaker 1

I'd like to point out that all figures expressed in today's call are all in Canadian dollars unless otherwise stated. The press release reporting our Q2 2024 results were published this morning and will be accessible from our website at kptishue inc.com. Please be aware that our MD and A will be posted on our website and will also be available on SEDAR. Finally, I would ask that you during the call to refer to the presentation to be prepared to accompany these discussions, which is also available on our website. We also appreciate during the Q and A period for you to limit your questions to 2.

Speaker 1

Thank you for your collaboration, ladies and gentlemen. I'll now turn the call over to Dino Bianco, our CEO. Dino?

Speaker 2

Thank you, Mike. Good morning, everyone, and thank you for joining us for our 2nd quarter earnings call for fiscal 2024. We delivered against expectations in the Q2 of 2024 with revenue driven profitability generating more than $65,000,000 in adjusted EBITDA. In the consumer segment, we brought added innovation and capacity to the Canadian facial tissue market to build our leadership status with a 42.8 percent share, while maintaining our number 1 and 2 positions in the bathroom tissue and paper towel categories respectively. We also continued growing our away from home business on the strength of increased sales and adjusted EBITDA year over year and sequentially.

Speaker 2

We are pleased with the strong momentum across all our business units, both in Canada and the U. S. And despite a labor disruption, our Crabtree Quebec facility that has since been resolved with a 5 year collective bargaining agreement, we are very pleased with our results. A margin management standpoint, we recently announced a price increase in our consumer segment to mitigate escalating pulp prices that are approaching peak levels. This pricing adjustment along with other productivity initiatives will ensure we continue to drive profitable growth.

Speaker 2

Now let's take a look at our quarterly numbers on Slide 6. Revenue growth of 9.3% in the Q2 of 2024 can mainly be attributed to higher sales volume, favorable sales mix in the consumer segment and improved pricing year over year. Revenue was also positively impacted by foreign exchange fluctuations on U. S. Dollar sales.

Speaker 2

Canadian revenues increased 5.2% in the 2nd quarter, while the U. S. Improved 14.8%. Robust revenue in the U. S.

Speaker 2

Continued to be fueled by new business growth. Adjusted EBITDA was up 18.6% year over year to $65,300,000 in the second quarter, mainly driven by enhanced sales volume, improved sales mix, improved prices and lower pulp costs. These factors were partially offset by several items. Michael will provide you with the details in his financial review. On Slide 7, pulp average prices in Canadian dollars increased as high as 21.6% in the Q2 of 2024 from the previous quarter, while year over year average prices for NBSK and BEK were up 14.5% 18.4% versus Q2 2023.

Speaker 2

In fact, NBSK prices in Canadian dollars reached a record level during the Q2 of 2024. Based on industry forecast, pulp prices are expected to remain elevated over the course of the year. And as a result, we announced the price increase for our consumer segment that will be effective in early September. Let's move on to our operations on slide 8. Production rates have progressed according to plan at our facilities, while the North American market continues to remain highly utilized in tissue.

Speaker 2

Our upcoming paper machine in Sherbrooke is on schedule with the start up on track for Q4 2024. Our new facial tissue assets in Gatineau and Sherbrooke are continuing to see expectations and produce high quality products and an expanded portfolio. Network CAD paper and converting output is ahead of last year, which is allowing us to meet the increased demand of premium products from our customers. And finally, we ratified a 5 year collective bargaining agreement at our Crabtree facility that should provide us with production stability going forward. Turning to our facial market update on Slide 9.

Speaker 2

As mentioned in recent calls, the facial tissue category in Canada underwent a significant reset following the Kleenex exit from retail almost a year ago. SCOTIS continued to build on its leadership position in the Q2 with a 52 week market share rising to nearly 43%. As mentioned earlier, both our legacy and new facial lines at Sherbrooke and Gatineau are operating above plan. We also increased innovation with the launch of Scotty's pocket packs for consumers on the go and introduced new ultra soft and ultra soft with lotion SKUs to meet the consumers' needs for premium facial tissue. In addition, we strategically added marketing support behind Scotty's House and Home Design Series as well as sponsorship of the Canada's Got Talent television show.

Speaker 2

All of this has resulted in increased investments in the Scotty's brand. Now let's move on to brand support on slide 10. We maintain ongoing support for our multiple brands to drive awareness and continue to drive share growth. For example, we offered consumers the chance to win 1 of 3 VIP experiences, each worth approximately $10,000 at an NHL playoff game. We also introduced only in Canada promotions to highlight the leadership position of our brands in Canada.

Speaker 2

On Bonterra, in Q2 2024, we also increased distribution and support with targeted media to expand the awareness and trials of the sustainable brand for environmentally conscious consumers. In addition, we released a unique cashmere ultra luxe bathroom guide, setting the standard for restaurant bathroom excellence by recognizing some of the most beautiful restaurant bathrooms in Toronto. This guide, which uses an exclusive 3 Flower rating system, evaluates restaurant bathrooms on a set list of criteria such as lighting, amenities and comfort. We look forward to expanding this concept in the coming months. Turning to Slide 11, the data presented is taken from Nielsen.

Speaker 2

It shows branded market share performance over a 52 week period ending June 15, 2024. I am pleased to report that our bathroom tissue is recovering after a high inflationary period during the last couple of years. Facial tissue and paper towel, meanwhile, continue to grow share based on investments in our brands, strong go to market and retail activation. Let's look at the Away From Home segment on Slide 12. We generated robust adjusted EBITDA that improved double digits over Q2 2023 and Q1 20 24.

Speaker 2

Sales volume improvements both year over year and sequentially drove strong profitability in the 2nd quarter with seasonality a contributing factor on a sequential basis. Looking ahead, away from home converting asset performance continues to support higher volume, while the start up of our Sherbrooke paper machine in the latter part of the year will provide internal paper for our AFH business, thus reducing our external requirements. Finally, on AFH, sales volume continues to track well despite an uncertain economic environment. I will now turn the call over to Michael.

Speaker 3

Thank you, Dino, and good morning, everyone. Please turn to Slide 13 for a summary of our financial performance for the Q2 of 2024. As Dino mentioned, we generated an adjusted EBITDA of $65,300,000 on sales of $509,800,000 a strong improvement and profitable growth year over year. Net income decreased $3,900,000 from $14,500,000 in Q2 2023, totaling $10,600,000 in the Q2 of 2024. The year over year decline can be explained by several factors, including a higher foreign exchange loss of 12,800,000 dollars and a greater depreciation expense of $5,200,000 These factors were partially offset by increased EBITDA of 10,300,000 dollars lower interest expense and other finance costs of $1,700,000 reduced income tax expense of 1,500,000 and a loss on the sale of fixed asset of $1,100,000 that happened in Q2 2023 that did not reoccur.

Speaker 3

In the quarterly segments in view on Slide 14, revenue from our consumer business grew 10% year over year $421,900,000 on stronger volume, favorable sales mix and higher selling prices. Our consumer segment also benefited from a positive ForEx impact on U. S. Dollar sales in the quarter. In the Away From Home segment, our revenue improved 6.1% year over year and 17% sequentially to $87,900,000 in the 2nd quarter for the same reason as we explained for our consumer business.

Speaker 3

RFH segment delivered revenue growth both in the U. S. And Canada, which highlight Dino's point that we received solid sales contribution from all segments and regions. Consumer adjusted EBITDA in the 2nd quarter totaled $60,300,000 compared to $53,300,000 in Q2 2023 with a margin of 14.3% versus 13.9% for the same period last year. On a sequential basis, consumer adjusted EBITDA declined 2 point $3,000,000 from Q1 2024.

Speaker 3

For our AFH business, EBITDA of $9,600,000 in the first quarter was up double digits year over year and in the second quarter was up double digits year over year and sequentially. AFH EBITDA increased $3,800,000 from Q2 2023 with a robust margin of 10.9%, while sequentially the AFH adjusted EBITDA improved $1,800,000 from Q1 2024. Moving to slide 15, we review consolidated revenue for Q2 2024, which expanded by $43,500,000 or 9.3 percent year over year. The increase was mainly driven by higher sales volume, higher selling prices in our consumer and AF hedge businesses and a positive FX impact. On a geographic basis, revenue in Canada rose $13,800,000 or 5.2 percent year over year, while U.

Speaker 3

S. Revenue grew by 29.7 percent $25,700,000 or 14.8 percent. On Slide 16, we look at our year over year profitability for the Q2. Adjusted EBITDA increased by $10,300,000 to $65,300,000 in the quarter, resulting in a margin of 12.8% compared to 11.8% for the same period last year. Numerous factors contributed to generating this healthy adjusted EBITDA in the Q2, which included favorable sales mix, higher selling prices and lower pulp costs compared to last year.

Speaker 3

And these items were partially offset by higher manufacturing overhead expenses, increased warehousing expenses and higher SG and A costs. Now if we move to Slide 17, where we compare Q2 revenue sequentially to Q1 2024. Our revenue increased $30,400,000 or 6.3 percent mainly due to higher selling prices, improved sales volume and a positive FX impact here as well. Geographically, revenue in Canada rose by $12,800,000 or 4.8 percent, while the revenue in the U. S.

Speaker 3

Grew by $17,600,000 or 8.2%. On slide 18, our adjusted EBITDA in the 2nd quarter declined slightly by 1,800,000 dollars or 2.7 percent to $65,300,000 mainly due to increased manufacturing overhead and higher pulp prices. These factors were partially offset by our selling price increase, increased sales volume, as well as the reduced freight, warehousing, SG and A and marketing expenses. As a result, our adjusted EBITDA margin was 12.8% in the 2nd quarter, down 120 basis points sequentially from 14% in Q1. Now turning to our balance sheet and financial position on Slide 19.

Speaker 3

Our cash position reached $127,200,000 at the end of the second quarter, an increase of $10,100,000 from Q1 twenty twenty four. The sequential increase in cash explained by a strong EBITDA performance in the 2nd quarter combined with reduced working capital. Our long term debt at the quarter end stood at $1,010,000,000 which was down $97,700,000 sequentially. This was primarily due to the reclass of $125,000,000 in senior secured notes that are payable in April 2025. Our net debt meanwhile increased by $22,700,000 sequentially to $1,050,000,000 largely based on spending related to the Sherbrooke expansion project.

Speaker 3

As a result, our net debt to last 12 months adjusted EBITDA ratio remained stable in the 2nd quarter versus the previous quarter at 4.0 times. As our net debt was offset by greater adjusted EBITDA over the last 12 months. On a year over year basis, our leverage ratio significantly improved from the 5 point 7 times in Q2 2023. In terms of total liquidity, we had 400 and $28,700,000 available at the end of the quarter. In addition, we had $16,600,000 of cash that was held for the Sherbrooke expansion project.

Speaker 3

And to conclude my section, we will review the capital spending on Page 20. CapEx for Q2 totaled 50,400,000 dollars which included $46,200,000 for the Sherbrooke Expansion project. At the halfway mark for the fiscal year, total CapEx reached 100,400,000 dollars So we're well within our expected range for the full year to be between $200,000,000 $220,000,000 Thank you for joining us this morning, and I'll now turn the call back to Dino.

Speaker 2

Great. Thank you, Michael. Please turn to Slide 21 for a quick word on our sustainability focus. On this page, you will find our updated 2,030 targets that were covered in our last quarterly call. On July 22, we released our new sustainability report, which tracks our progress against these goals.

Speaker 2

We are very pleased with our progress, and I encourage you to consult the full report for more details. Let's turn to Slide 22 for my closing comments. We received strong top line contributions from all our business segments and geographic regions in the Q2 to drive growth and margins. Price increases have been announced for early September to mitigate escalating pulp prices, while we continue to invest in our brands to enable long term share growth. We will increase capacity to meet strong demand through our share book expansion in new facial lines.

Speaker 2

Our Way From Home segment continues to deliver against a sustainable profit model. Our leverage ratio is expected to remain within its current range based on the final year of spending in Sherbrooke in 2024. And finally, we keep investing in our organization and culture to drive future growth. Now let's turn our attention to the outlook for the Q3 of 2024. We anticipate adjusted EBITDA will be in the range of Q2 2024, despite escalating pulp prices and the impact of the Crabtree labor settlement.

Speaker 2

We will now be happy to take your questions.

Operator

Thank you, And your first question will be from Hamir Patel at CIBC Capital Markets. Please go ahead.

Speaker 4

Hi, good morning. Good morning. You announced a high single digit price like in the Canadian consumer business for September. Has that been accepted by your major customers? And have your competitors announced a similar level of increase?

Speaker 2

Yes. Hamir, thank you for the question. Yes, I mean, we've been working with our customers and showing the justification for the price increase. Obviously, are very interested in the rationale for the price increase and many of them do track the commodities very closely. So I think they all understand the need for pricing when you factor particularly in Canadian dollars for the Canadian side of the business.

Speaker 2

So I would say that process is always challenging no matter when. Nobody wants to hear about a price increase. In fact, nobody wants to take a price increase, particularly with the state of the economy. But this one is necessary and justified. And I think we have been able to get through most customers all customers, I should say, now for an effective early September date.

Speaker 4

Fair enough.

Speaker 2

Yes. As far as competition, we don't hear anything official, but we understand that other tissue companies are also showing the same rationale for pricing.

Speaker 4

Right. Okay. That makes sense. We've seen Suzano. It looks like they're doing some trials with one of their new products that can replace softwood in certain applications.

Speaker 4

Do you see any potential for you to benefit from some of these innovations on the hardwood side or just given your quality requirements, you're not going to kind of break away from the NBSK amounts that you use right now?

Speaker 2

Yes. Amir, you're well informed. Good obviously, we have great partnerships with our pulp suppliers and continue to work with them and continue to work internally on optimizing our fiber basket to deliver the same quality with better pricing. So that product that you're talking about is one that we are looking at and trialing to see if there's potential in our network. 1st and foremost though, we need to deliver against our quality specs, whether it's our own brands or any private label that we supply.

Speaker 2

So that's always our first stage gate. And if we can get through that and hopefully get a price improvement, that will be a win win. So we are looking at that and continue to look at fiber optimization as part of our productivity initiatives.

Speaker 4

Okay. Fair enough. Thanks, Stephen. That's all I had. I'll turn it over.

Speaker 2

Thanks, Sabir.

Operator

Next question will be from Sean Steuart at TD Cowen. Please go

Speaker 5

ahead. Thanks. Good morning, everyone. Good morning. Good morning.

Speaker 5

First question, hoping for some updated perspective on the away from home margin trend. I think for a while, the long term target you guys have articulated has been high single digit EBITDA margins. You tracked better in the last couple of quarters with some momentum. Any thoughts with respect to rethinking long term margin potential at the Away From Home segment? Yes.

Speaker 2

It's a great question, Sean. I will be honest, I mean, and I think probably most of us on the call, the AFH business turnaround has been better than I expected and faster than I expected. I have said high single digits and maybe more stability around low double digits. They're getting there now. I was expecting that over time.

Speaker 2

So do I think there's more there? Yes, I do. And I think the next big step for AFH is once we start getting more internal paper because they are continuing we are paper constrained and they are the ones continuing to buy paper on the market. So once our new paper machine comes up later this year, there won't be an immediate benefit, but certainly over the ramp up curve over the next 18 to 24 months, they will start to see that benefit. And I think that'll be a step change.

Speaker 2

Obviously, they've done great work on volume growth. They've done great work on pricing management, SKU portfolio, operations through OpEx. And now if we can get internal paper, I think that'll be full bundle. And I think they should now be in the low double digit EBITDA once those things come into place.

Speaker 5

Okay. Thanks for that, Dino. And then just following on the share book ramp, you gave us the timeframe. Can you remind us just the EBITDA, ultimate EBITDA incremental contribution you're expecting once that asset is fully ramped up and you realize all the benefits? Is there a number you can put on that?

Speaker 2

We don't usually quote that number, so I'm not going to. Sorry for that, Sean. But I will tell you, one of the benefits of what that paper machine is going to do for us is just as I mentioned for away from home is in sourcing some paper that we're buying in the market. And that does 2 things. It provides a lower cost, but more importantly or just as important, it provides consistent high quality when you're internally sourcing your paper, which should make our whole network run better, our converting lines and so forth.

Speaker 2

So that paper machine, we said it will start in Q4. It is getting ready to ramp up. So we may be able to get a few days earlier than expected. And we should start to see some benefit from that in Q4. The primary use will be for internal paper.

Speaker 2

The second big use for that line will paper machine will be to feed the facial lines that we've just put in place. So the growth in facial and that asset that paper machine we have purchased is well set up to provide a very high quality facial. So and then of course we'll see some incremental case production from that line across our converting network that assets are already in place for that. So we're looking forward to that and much needed quite frankly given our paper supply situation.

Speaker 5

Understood. Okay. Thanks very much, Neil. Appreciate

Speaker 2

it. Yes. Thanks,

Operator

And your next question will be from Zachary Evershed at National Bank. Please go ahead.

Speaker 6

Good morning, everyone. Thanks for taking my questions.

Speaker 2

Good morning.

Speaker 6

Given the announcement of the Clearwater Sofitel transaction, what's your view of participating in industry consolidation?

Speaker 2

Yes. I think it's a safe bet to say that Kruger will look at every opportunity to grow. And as I've mentioned before, that includes acquisitions, greenfield sites or increased assets at existing sites. So we look at all of that. So anytime there's a company for sale, we will be looking at it at the table.

Speaker 2

So I'll say that. Sometimes we're successful, sometimes there may not be the right fit. But we are in a growth mode and we'll continue to look at all options. Now that the Clearwater has come to closure, obviously, we now understand what the future market will look like and also now reassessing where our opportunities continue to be for future growth across North America.

Speaker 6

That makes sense. Thanks. And for number 2, we're seeing some commentary suggesting pulp prices could actually break later this year given activity in China. Your outlook highlights pulp costs that remain elevated through the rest of the year. Are those both the same outlook?

Speaker 6

You're just referring to elevated versus a year ago? Or does your current forecast call for steady pulp prices?

Speaker 2

Yes. Look, there's a lot of volatility in pulp, even the pulp experts, a lot of dynamics that start to change. I would say, certainly, China has come down. China escalated rapidly early. By amplitude and speed.

Speaker 2

And now they're starting to just back because the underlying fundamentals aren't there. The North American market remains at elevated levels. I anticipate based on the various forecasts that we follow that this market will likely go sideways now. I'm not sure how much more above that it will go, but it certainly will not decline at any rapid rate. My guess is it will go sideways.

Speaker 2

And one of the things our organization is trying to do as it relates to our pricing business. We have certain part of our business mainly on the private label and away from home side where we have contracts that renew every 3 months. So those will stay close to market. And where we price to market, mainly on Canadian consumer side, we also want to mimic that, not on a contract basis, but in terms of how we respond to changing pulp prices both up and down. And I think you'll start to see us be a little more closer to the curve without doing a bunch of price changes, but a little closer to the curve as it relates to the commodity changes, not just pulp, obviously other key inputs as well.

Speaker 2

And so we announced the September increase based on the high pulp prices. We think that's the right level to be at. We think pulp will be at that level for a while. And then we'll watch it

Speaker 6

in the New Year to

Speaker 2

see if we need to make any further adjustments.

Speaker 6

Thank you very much. I'll turn it over.

Operator

Thank you. Next question will be from Frederic Tremblay at Desjardins. Please go ahead.

Speaker 4

Thanks. Good morning. Good morning. Most of my questions have been answered, but I do have one on AFH volume and just maybe better understanding of volume trends there. Obviously, seeing a volatile economic environment and some sectors like restaurants are going through a tough time right now it seems.

Speaker 4

So just wanted to better understand the reasons or the drivers behind the volume success that you've had in AFH and sort of get your outlook on things based on what you're seeing from your customers right now?

Speaker 2

Yes, it's a good question. I mean, the reality is the market hasn't actually recovered to pre COVID level. So the market has been improving since the trough in 2020, but still has not achieved the levels. Our growth has come from the fact for 2 things. 1 is, more of our growth is coming from the U.

Speaker 2

S. Market, where we're actually gaining share. We're a smaller player there. So anything we do with incrementality is contributing to our growth, whereas in Canada, we're more growing with the market. And we are great partners with a couple of key away from home customers or distributors who happen to be growing at above the market.

Speaker 2

So we're also growing quickly given our relationship with them. And don't forget, our wafer oil business covers many sectors, not just restaurants and obviously hospitality or some that we're watching right now with the economy. We also cover industrial and healthcare and various other segments as well who have different growth trajectories despite what could be a potential economic slowdown. So I think the away from home volume is real. It's based on a strong foundation.

Speaker 2

And it is benefiting more on the U. S. Side as we grow share with Canada kind of being steady growth with market.

Speaker 4

Very helpful. That's all I had. Thank you.

Speaker 2

Thank you.

Operator

Thank you. And at this time, Mr. Bianco, we have no further questions. Please proceed.

Speaker 2

Great. So I'll wrap it up here. I just want to thank everybody for joining us on the call today. We're very pleased with our results, and we look forward to speaking with you again following the release of our Q3 results. So thank you all.

Speaker 2

Have a great day.

Operator

Thank you, sir. Ladies and gentlemen, this does indeed conclude the conference call for today. Once again, thank you for attending. And at this time, we do ask that you please disconnect your lines.

Powered by Quartr

Key Takeaways

  • Delivered 9.3% revenue growth to C$509.8 million and an 18.6% increase in adjusted EBITDA to C$65.3 million, driven by higher volume, favorable mix, improved pricing and lower pulp costs.
  • Announced a high-single-digit price increase in the consumer segment effective September to offset record-high pulp prices, which are expected to remain elevated through year-end.
  • Maintained market leadership with 42.8% share in Canadian facial tissue and #1/#2 positions in bathroom tissue and paper towels, supported by new innovations (e.g., Scotty’s pocket packs) and targeted marketing.
  • Advanced key operational projects: new facial tissue lines in Gatineau and Sherbrooke are outperforming plan, the Sherbrooke paper machine remains on track for Q4 2024 start-up, and a 5-year collective bargaining agreement resolved the Crabtree labor disruption.
  • Away From Home segment posted double-digit EBITDA growth year-over-year and sequentially, with strong volume gains and the upcoming Sherbrooke paper machine expected to supply internal paper and further enhance margins.
AI Generated. May Contain Errors.
Earnings Conference Call
KP Tissue Q2 2024
00:00 / 00:00